Coxiella burnetii, the etiologic agent of Q fever, is unique among the rickettsiae in that it undergoes a host-dependent phase variation. Virulent phase I is isolated from nature, whereas the relatively avirulent phase II is selected for during serial laboratory passage in nonimmunologically competent hosts such as eggs or tissue culture (2) . Recognized since 1956, phase variation has been defined serologically (25) . Compositional analysis of the lipopolysaccharides (LPSs) of phases I and II C. burnetii has demonstrated that this phase variation parallels the smooth-to-rough LPS variation of gram-negative enteric bacteria (22) . This intrastrain heterogeneity of LPS structure has been extensively examined. Variation between strains, however, has not been well studied.
We have recently used the procedure of sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and silver staining of LPS to identify within the Nine Mile strain of C. burnetii a third LPS type believed to be structurally intermediate between the phases I and II LPSs that could not be identified by standard serological methods (8) . The variant with the intermediate LPS chemotype was isolated from the placenta of a guinea pig infected almost a year previously with phase I organisms (5) . The unusual source of this organism led us to consider (8) potential roles for LPS variation in the establishment of chronic or persistent infections by C. burnetii. To further explore possible roles for LPS variation in the capacity of C. burnetii to establish chronic infections, a number of C. burnetii isolates from chronic Q fever patients and a variety of other sources were screened for antigenic variation of the phase I-type LPS on silver-stained polyacrylamide gels and by immunoblot analysis.
C. burnetii isolates were screened for antigenic or structural variation of the phase I-type LPS on silver-stained polyacrylamide gels (Fig. 1A) and by immunoblotting either with an anti-C. burnetii Nine Mile phase I aptiserum (Fig.  1B) or with an anti-C. burnetii Priscilla phase I antiserum (Fig. 1C) (Fig. 1A) . Minor differences in profile were observed within these groups. Group 1 had LPS that was similar in profile to the LPS of C. burnetii Nine Mile. All of these isolates were from primary (acute) Q fever, ticks, or milk and were from various locations around the world. The other two groups were among isolates from chronic Q fever patients. Group 3 was comprised of the S, Ko, G, and L isolates. Group 2, consisting of the Priscilla, P, K, and F isolates, appeared even more distinctive. LPSs from this latter group cross-reacted weakly, or not at all, with an antiserum prepared in rabbits against the Nine Mile strain of C. burnetii (Fig. 1B) Table 1 , were grown in embryonated chicken eggs and purified by Renografin (E. R. Squibb & Sons, Princeton, N.J.) density gradient centrifugation (31) . LPSs were extracted by the hot phenol-water procedure (30) and were subjected to SDS-PAGE on 12.5% polyacrylamide gels as described previously (8, 9) , with silver staining by the procedure of Tsai and Frasch (27) . Immunoblotting was done as described previously (8, 9) , except the antisera used here were produced in rabbits against Formalin-killed intact cells of C. burnetii Nine Mile (B) or C. burnetii Priscilla (C) as follows. Hyperimmune rabbit antisera were prepared against phase I C. burnetii Nine Mile and Priscilla. Briefly, 1 ml of Formalin-killed C. burnetii (1 mg [dry weight] per ml, 0.14 M NaCl) was emulsified in 1 ml of Freund complete adjuvant (Sigma Chemical Co., St. Louis, Mo.) and administered intramuscularly. After 30 days, two intravenous injections of Formalin-killed C. burnetii antigen in 0.14 M NaCl were given. Rabbits were bled 7 days after the last immunizing injection. Based upon silver-stained SDS-PAGE profiles of the purified LPS, it appears that at least three basic groups of phase I-type LPS can be established. One group, typified by the Nine Mile strain of C. burnetii, was comprised of C. burnetii isolates from a variety of sources. The other two groups were primarily from isolations made from chronic Q fever patients. The LPSs of C. burnetii are not chemically characterized well enough to explain the migration patterns or antigenicity of the multitude of bands seen on SDS-PAGE. However, by analogy with SDS-PAGE profiles of the LPS of enteric bacteria (7, 10, 15, 19) , the migration of C. burnetii phase I LPS is similar to that of a smooth-type LPS. Like enterobacterial LPS (12) , the terminal oligosaccharides of C. burnetii LPS make up the dominant immunogenic and antigenic determinants (23) . It is likely, therefore, that the 0-antigen equivalents on the LPS of the Priscilla, P, K, and F groups differ from the corresponding structures of the other groups, although some epitopes, particularly those on the faster-migrating LPS species, seem to be shared. Although the technique used here may not detect minor variations, it does establish groups that show major differences in a prominent surface antigen and therefore provides a basis for more detailed structural analysis of phase I LPS variants, comparisons of virulence between strains, and cross-protection experiments between vaccine and challenge strains that vary in this antigenic determinant.
Recently, restriction endonuclease mapping of C. burnetii plasmids has demonstrated an association between plasmid type and disease (21 The results presented here demonstrate that variants of C. burnetii exist, thus raising the question of the relative proportion of each in different populations.
The finding that the LPS of one group of chronic Q fever isolates was antigenically distinct from the Nine Mile strain LPS presents somewhat of a paradox in that elevated serum immunoglobulins G and A titers against the phase I antigen (LPS) are considered diagnostic of Q fever endocarditis (20, 28) , and all patients from which these isolations were made demonstrated high serum antibody titers against phase I C. burnetii Nine Mile (20; M. G. Peacock, unpublished observations). The specificity of the rabbit antiserum used here may be due to the immunization procedure or may reflect different epitopes recognized by humans during chronic infection. Additional work is needed to assess the degree of antigenic cross-reactivity between these LPSs. Despite these considerations, it is clear that one group of C. burnetii isolates possessed an LPS that is antigenically distinct from that of C. burnetii Nine Mile phase I. This observation might explain the occasional reports (18, 26) of Q fever endocarditis without anti-phase I (LPS) antibodies elevated to the titers usually considered as diagnostic.
The infectious nature of the Q fever agent C. burnetii plus increasing concern over the chronic forms of the disease has led to renewed interest in the vaccination of high-risk groups such as laboratory or abattoir workers. A number of vaccine preparations composed of Formalin-killed intact organisms have been tested in humans (1, 13, 14, 24, 29) . These vaccines have been believed to be effective and safe as long as skin testing was done and sensitive individuals were excused from vaccination (13) . Critical to the success of any vaccine, however, is the degree of antigenic variation in the causative agent(s). LPS appears to be the predominant surface antigen that varies between phases (8). It has been shown that vaccines composed of Formalin-killed phase I cells are 100 to 300 times more vaccinogenic than vaccines composed of phase II cells (16) . Recently, this observation has been interpreted as indicating that the phase I antigen (LPS) is the protective immunogen (14) . In support of this are demonstrations of protection by trichloroacetic acid (3, 4, 11) and phenol-water-extracted phase I LPS (3). The extent of antigenic variation among isolates of phase I C. burnetii from nature is therefore of additional interest regarding the efficacy of Q fever vaccines.
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